Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Current Assets (2010 - 2026)

Talphera (TLPH) posted Current Assets of $18.0 million for Q2 2026, down 15.7% on a QoQ basis from $21.3 million in Q1 2026, and up 133.72% year-over-year from $7.7 million in Q2 2025.

Analysis

Talphera (TLPH) Current Assets (2010 - 2026) Analysis & Trends

Talphera has reported Current Assets for 17 years, with the latest figure at $18.0 million in Q2 2026.

  • On a quarterly basis, Current Assets rose 133.72% year-over-year to $18.0 million in Q2 2026; TTM through Jun 2026 was $18.0 million, a 133.72% increase from a year earlier, with the FY2025 full-year figure at $20.9 million, up 121.94% from the prior year.
  • Current Assets was $18.0 million for Q2 2026 at Talphera, down from $21.3 million in the prior quarter.
  • The five-year high for Current Assets was $42.8 million in Q1 2022, with the low at $6.2 million in Q1 2025.
  • Average Current Assets over 5 years is $18.3 million, with a median of $17.7 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2026: Current Assets slumped 72.38% in 2023, then jumped 245.47% in 2026.
  • Over 5 years, Current Assets stood at $24.6 million in 2022, then sank by 52.88% to $11.6 million in 2023, then fell by 18.65% to $9.4 million in 2024, then soared by 121.94% to $20.9 million in 2025, then dropped by 13.94% to $18.0 million in 2026.
  • The last three Current Assets figures came in at $18.0 million (Q2 2026), $21.3 million (Q1 2026), and $20.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.07 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.74 Bn
10 Talphera 92.90 Mn 92.90 Mn - 17.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.99 Mn
Mar 31, 2026 21.34 Mn
Dec 31, 2025 20.90 Mn
Sep 30, 2025 21.92 Mn
Jun 30, 2025 7.70 Mn
Mar 31, 2025 6.18 Mn
Dec 31, 2024 9.42 Mn
Sep 30, 2024 12.20 Mn
Jun 30, 2024 16.04 Mn
Mar 31, 2024 19.95 Mn
Dec 31, 2023 11.58 Mn
Sep 30, 2023 14.42 Mn
Jun 30, 2023 8.84 Mn
Mar 31, 2023 17.35 Mn
Dec 31, 2022 24.57 Mn
Sep 30, 2022 24.54 Mn
Jun 30, 2022 32.00 Mn
Mar 31, 2022 42.81 Mn
Dec 31, 2021 50.49 Mn
Sep 30, 2021 51.75 Mn